至純科技(603690.SH):公司是國內在多個高端品類上首家打破國外廠商壟斷的濕法設備供應商
格隆匯2月26日丨至純科技(603690.SH)在投資者互動平台表示,公司作為濕法設備的後起之輩,2017-2018年開始投入半導體濕法設備,比同行晚進入市場十幾年,在市佔率方面正在進行追趕;但公司在設備製造方面主要聚焦晶圓製造難度較高的前道工藝,主要應用於擴散、光刻、刻蝕、離子注入、薄膜沉積等關鍵工序段前後,高端產品包括 SPM 高温硫酸、去膠、晶背清洗等。公司是國內在多個高端品類上首家打破國外廠商壟斷的濕法設備供應商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.